These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 33806229)
21. Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions. Zamarin D; Palese P Future Microbiol; 2012 Mar; 7(3):347-67. PubMed ID: 22393889 [TBL] [Abstract][Full Text] [Related]
22. Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer. Chai Z; Zhang P; Fu F; Zhang X; Liu Y; Hu L; Li X Virol J; 2014 May; 11():84. PubMed ID: 24885546 [TBL] [Abstract][Full Text] [Related]
23. Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death. Koks CA; Garg AD; Ehrhardt M; Riva M; Vandenberk L; Boon L; De Vleeschouwer S; Agostinis P; Graf N; Van Gool SW Int J Cancer; 2015 Mar; 136(5):E313-25. PubMed ID: 25208916 [TBL] [Abstract][Full Text] [Related]
24. A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular Carcinoma. Abdullahi S; Jäkel M; Behrend SJ; Steiger K; Topping G; Krabbe T; Colombo A; Sandig V; Schiergens TS; Thasler WE; Werner J; Lichtenthaler SF; Schmid RM; Ebert O; Altomonte J J Virol; 2018 Dec; 92(23):. PubMed ID: 30232179 [TBL] [Abstract][Full Text] [Related]
25. Cell-type-specific innate immune response to oncolytic Newcastle disease virus. Biswas M; Kumar SR; Allen A; Yong W; Nimmanapalli R; Samal SK; Elankumaran S Viral Immunol; 2012 Aug; 25(4):268-76. PubMed ID: 22808996 [TBL] [Abstract][Full Text] [Related]
26. Regression of solid breast tumours in mice by Newcastle disease virus is associated with production of apoptosis related-cytokines. Raihan J; Ahmad U; Yong YK; Eshak Z; Othman F; Ideris A BMC Cancer; 2019 Apr; 19(1):315. PubMed ID: 30947706 [TBL] [Abstract][Full Text] [Related]
27. Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy. Ricca JM; Oseledchyk A; Walther T; Liu C; Mangarin L; Merghoub T; Wolchok JD; Zamarin D Mol Ther; 2018 Apr; 26(4):1008-1019. PubMed ID: 29478729 [TBL] [Abstract][Full Text] [Related]
28. Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion. García-Romero N; Palacín-Aliana I; Esteban-Rubio S; Madurga R; Rius-Rocabert S; Carrión-Navarro J; Presa J; Cuadrado-Castano S; Sánchez-Gómez P; García-Sastre A; Nistal-Villan E; Ayuso-Sacido A Cells; 2020 Jun; 9(6):. PubMed ID: 32516884 [TBL] [Abstract][Full Text] [Related]
29. Design and Production of Newcastle Disease Virus for Intratumoral Immunomodulation. Vijayakumar G; Zamarin D Methods Mol Biol; 2020; 2058():133-154. PubMed ID: 31486036 [TBL] [Abstract][Full Text] [Related]
31. Newcastle diseases virus strain V4UPM displayed oncolytic ability against experimental human malignant glioma. Zulkifli MM; Ibrahim R; Ali AM; Aini I; Jaafar H; Hilda SS; Alitheen NB; Abdullah JM Neurol Res; 2009 Feb; 31(1):3-10. PubMed ID: 18937888 [TBL] [Abstract][Full Text] [Related]
32. Gene expression profiling in PC12 cells infected with an oncolytic Newcastle disease virus strain. Balogh A; Bátor J; Markó L; Németh M; Pap M; Sétáló G; Müller DN; Csatary LK; Szeberényi J Virus Res; 2014 Jun; 185():10-22. PubMed ID: 24637408 [TBL] [Abstract][Full Text] [Related]
33. Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance. Schirrmacher V Expert Opin Biol Ther; 2015; 15(12):1757-71. PubMed ID: 26436571 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of Apoptosis Induction by Newcastle Disease Virus LaSota Strain in Human Breast Carcinoma Cells. Kalantari A; Farashi Bonab S; Keyvanfar H; Mortazavi P Arch Razi Inst; 2020 Oct; 75(3):367-376. PubMed ID: 33025777 [TBL] [Abstract][Full Text] [Related]
35. Oncolytic Newcastle disease virus expressing a checkpoint inhibitor as a radioenhancing agent for murine melanoma. Vijayakumar G; Palese P; Goff PH EBioMedicine; 2019 Nov; 49():96-105. PubMed ID: 31676387 [TBL] [Abstract][Full Text] [Related]
36. Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF-κB pathway in canine mammary carcinoma cells. Wang J; Li M; Li M Vet Comp Oncol; 2023 Sep; 21(3):520-532. PubMed ID: 37282822 [TBL] [Abstract][Full Text] [Related]
37. Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses. Zamarin D; Martínez-Sobrido L; Kelly K; Mansour M; Sheng G; Vigil A; García-Sastre A; Palese P; Fong Y Mol Ther; 2009 Apr; 17(4):697-706. PubMed ID: 19209145 [TBL] [Abstract][Full Text] [Related]
38. Apoptin enhances the oncolytic properties of Newcastle disease virus. Wu Y; Zhang X; Wang X; Wang L; Hu S; Liu X; Meng S Intervirology; 2012; 55(4):276-86. PubMed ID: 21865658 [TBL] [Abstract][Full Text] [Related]
39. Enhancement of the proapoptotic properties of newcastle disease virus promotes tumor remission in syngeneic murine cancer models. Cuadrado-Castano S; Ayllon J; Mansour M; de la Iglesia-Vicente J; Jordan S; Tripathi S; García-Sastre A; Villar E Mol Cancer Ther; 2015 May; 14(5):1247-58. PubMed ID: 25761895 [TBL] [Abstract][Full Text] [Related]
40. Cross-infection of tumor cells by contact with T lymphocytes loaded with Newcastle disease virus. Pfirschke C; Schirrmacher V Int J Oncol; 2009 Apr; 34(4):951-62. PubMed ID: 19287952 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]